Western blot analysis of the phosphorylation of ERK1/2

XZ Xiaoyang Zhang
MM Magdalini Matziari
YX Yixin Xie
DF David Fernig
RR Rong Rong
JM Jia Meng
ZL Zhi-Liang Lu
request Request a Protocol
ask Ask a question
Favorite

HEK293 and MCF-7 cells transiently transfected with kisspeptin receptor were used for phosphorylation assay of the extracellular signal-regulated kinase 1/2 (ERK1/2) After 24 hours following transfection, the cells were serum-starved in a serum-free medium (DMEM supplemented with 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.1% (w/v) bovine serum albumin (BSA), 2 nM L-glutamine, 0.2 unit/ml penicillin and 0.2 μg/ml streptomycin) overnight prior to any treatment. Assays were then conducted by stimulating the cells with KP-10 or KP phosphinic peptides. Following stimulation, the cells were placed on ice and solubilized with SDS-PAGE sample loading buffer supplemented with 5 mM sodium orthovanadate and completeTM protease inhibitor cocktail. Solubilized samples were boiled and then subjected to SDS-PAGE. Subsequently, proteins were electrotransferred onto polyvinylidene difluoride (PVDF) membranes for immunoblotting. Immunoblots were then assayed for phosphorylated ERK1/2 using a phospho-specific rabbit monoclonal antibody (1:1000) (phospho-p42/44 ERKs, Thr202/Tyr204) and for β-actin using a mouse monoclonal antibody (1:1000). Following incubation with IRDye® goat anti-mouse (1:5000) or anti-rabbit (1:10000) IgG (H + L) secondary antibody, the PVDF membranes were visualised using Odyssey® infrared imaging system (LI-COR, Lincoln, USA). Immunoblots were quantified by densitomery using the Odyssey® application software (version 3.0).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A